BEGLEY DAVID J ET AL: "Lysosomal storage diseases and the blood-brain barrier", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, vol. 14, no. 16, 1 June 2008 (2008-06-01), pages 1566-1580, XP002582829, ISSN: 1381-6128 (B1)

WO-A2-2009/018122 (B1)

BRAUN ET AL.: 'Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase' PROC. NATL. ACAD. SCI. USA vol. 90, December 1993, pages 11830 - 11834, XP055020541 (B1)

DATABASE NUCLEOTIDE [Online] 1992 'Homo sapiens iduronate 2-sulfatase (IDS), transcript variant 1, mRNA', XP008159297 Retrieved from NCBI Database accession no. NM_000202.5 (B1)

ERIC KA-WAI HUI ET AL: "Tumor Necrosis Factor Receptor-IgG Fusion Protein for Targeted Drug Delivery across the Human Blood-Brain Barrier", MOLECULAR PHARMACEUTICS, vol. 6, no. 5, 5 October 2009 (2009-10-05) , pages 1536-1543, XP055002799, ISSN: 1543-8384, DOI: 10.1021/mp900103n (B1)

ESTER ZITO ET AL: "Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2", EMBO REPORTS, vol. 6, no. 7, 1 July 2005 (2005-07-01), pages 655-660, XP055150221, ISSN: 1469-221X, DOI: 10.1038/sj.embor.7400454 (B1)

JERRY THOMPSON ET AL: "Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion", PROTEIN ENGINEERING, DESIGN AND SELECTION, vol. 14, no. 12, 1 December 2001 (2001-12-01), pages 1035-1041, XP055439051, GB ISSN: 1741-0126, DOI: 10.1093/protein/14.12.1035 (B1)

LU JEFF ZHIQIANG ET AL: "Expression in CHO Cells and Pharmacokinetics and Brain Uptake in the Rhesus Monkey of an IgG-Iduronate-2-Sulfatase Fusion Protein", BIOTECHNOLOGY AND BIOENGINEERING, vol. 108, no. 8, August 2011 (2011-08), pages 1954-1964, XP002692098, (B1)

LU JEFF ZHIQIANG ET AL: "Genetic Engineering of a Bifunctional IgG Fusion Protein with Iduronate-2-Sulfatase", BIOCONJUGATE CHEMISTRY, vol. 21, no. 1, January 2010 (2010-01), pages 151-156, XP002692096, (B1)

MCGRATH J P ET AL: "Bifunctional fusion between nerve growth factor and a transferrin receptor antibody", JOURNAL OF NEUROSCIENCE RESEARCH, WILEY-LISS, US, vol. 47, 1 January 1997 (1997-01-01), pages 123-133, XP002698610, ISSN: 0360-4012 (B1)

PARDRIDGE W M: "Blood-Brain Barrier Drug Targeting: The Future of Brain Drug Development", MOLECULAR INTERVENTIONS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, BETHESDA,MD, US, vol. 3, no. 2, 1 March 2003 (2003-03-01), pages 90-105, XP002993086, ISSN: 1534-0384, DOI: 10.1124/MI.3.2.90 (B1)

PARDRIDGE WILLIAM M: "Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses", BIOCONJUGATE CHEMISTRY, vol. 19, no. 7, July 2008 (2008-07), pages 1327-1338, XP002692094, (B1)

POLITO VINICIA ASSUNTA ET AL: "IDS Crossing of the Blood-Brain Barrier Corrects CNS Defects in MPSII Mice", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 85, no. 2, August 2009 (2009-08), pages 296-301, XP002692097, ISSN: 0002-9297 (B1)

QI LIN ET AL: "Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor", CANCER RESEARCH, AACR - AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 64, no. 6, 15 March 2004 (2004-03-15) , pages 2090-2095, XP002557871, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-3192-2 (B1)

RUBEN J BOADO ET AL: "IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 105, no. 3, 15 February 2010 (2010-02-15), pages 627-635, XP002622927, ISSN: 0006-3592, DOI: 10.1002/BIT.22576 [retrieved on 2009-10-08] (B1)

RUBEN J BOADO ET AL: "Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor", MOLECULAR PHARMACEUTICS, AMERICAN CHEMICAL SOCIETY, US, vol. 7, no. 1, 1 February 2010 (2010-02-01), pages 237-244, XP002669226, ISSN: 1543-8384, DOI: 10.1021/MP900235K [retrieved on 2003-12-03] (B1)

RUBEN J. BOADO ET AL: "AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys", JOURNAL OF BIOTECHNOLOGY, vol. 144, no. 2, 1 October 2009 (2009-10-01), pages 135-141, XP055020498, ISSN: 0168-1656, DOI: 10.1016/j.jbiotec.2009.08.019 (B1)

RUBEN J. BOADO ET AL: "Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier", BIOTECHNOLOGY AND BIOENGINEERING, vol. 99, no. 2, 1 February 2008 (2008-02-01), pages 475-484, XP055020493, ISSN: 0006-3592, DOI: 10.1002/bit.21602 (B1)

US-A1- 2004 229 250 (B1)

US-A1- 2005 142 141 (B1)

WO-A2-2008/022349 (B1)

BOADO RUBEN J ET AL: "Engineering and Expression of a Chimeric Transferrin Receptor Monoclonal Antibody for Blood-Brain Barrier Delivery in the Mouse", BIOTECHNOLOGY AND BIOENGINEERING, vol. 102, no. 4, March 2009 (2009-03), pages 1251-1258, XP002692095, (B1)